You are here

Study Estimating the Impact of Prevnar 13™ (13vPnC) on Invasive Pneumococcal Disease

Last updated on May 9, 2019

FOR MORE INFORMATION
Study Location
Kaiser Permanente Vaccine Study Center
Oakland, California, 94612 United States
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Invasive Pneumococcal Disease
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
0 +
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- Documented invasive pneumococcal disease (IPD), defined as recovery of an isolate of S
pneumoniae from a normally sterile site in a member of the surveillance population.

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

None

NCT01128439
Pfizer
Completed
Study Estimating the Impact of Prevnar 13™ (13vPnC) on Invasive Pneumococcal Disease

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now